1. Home
  2. CENTA vs ANIP Comparison

CENTA vs ANIP Comparison

Compare CENTA & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company Nonvoting

CENTA

Central Garden & Pet Company Nonvoting

HOLD

Current Price

$33.87

Market Cap

2.0B

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$78.51

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENTA
ANIP
Founded
1955
2001
Country
United States
United States
Employees
6000
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
CENTA
ANIP
Price
$33.87
$78.51
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$36.75
$110.00
AVG Volume (30 Days)
229.9K
294.9K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
N/A
3.32
Revenue
N/A
$206,547,000.00
Revenue This Year
$1.60
$21.01
Revenue Next Year
$2.04
$17.59
P/E Ratio
$13.52
$23.94
Revenue Growth
N/A
2.47
52 Week Low
$25.97
$56.71
52 Week High
$37.35
$99.50

Technical Indicators

Market Signals
Indicator
CENTA
ANIP
Relative Strength Index (RSI) 54.40 53.02
Support Level $31.16 $78.80
Resistance Level $35.12 $83.58
Average True Range (ATR) 0.84 2.41
MACD 0.04 -0.04
Stochastic Oscillator 50.75 46.30

Price Performance

Historical Comparison
CENTA
ANIP

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: